-
$1,500 Read More Ceronco Biosciences – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Ceronco Biosciences - Product Pipeline Review - 2015’, provides an overview of the Ceronco Biosciences’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Ceronco Biosciences... -
$1,500 Read More Bioncotech Therapeutics S.L. – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Bioncotech Therapeutics S.L. - Product Pipeline Review - 2015’, provides an overview of the Bioncotech Therapeutics S.L.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of B... -
$1,500 Read More Generon (Shanghai) Corporation Ltd. – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Generon (Shanghai) Corporation Ltd. - Product Pipeline Review - 2015’, provides an overview of the Generon (Shanghai) Corporation Ltd.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental... -
$1,500 Read More SK Biopharmaceuticals Co., Ltd. – Product Pipeline Review – 2015
Global Markets Direct’s, ‘SK Biopharmaceuticals Co., Ltd. - Product Pipeline Review - 2015’, provides an overview of the SK Biopharmaceuticals Co., Ltd.’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipelin... -
$1,500 Read More Oncomatryx Biopharma, S.L. – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Oncomatryx Biopharma, S.L. - Product Pipeline Review - 2015’, provides an overview of the Oncomatryx Biopharma, S.L.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Oncoma... -
$1,500 Read More Foresee Pharmaceuticals, LLC – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Foresee Pharmaceuticals, LLC - Product Pipeline Review - 2015’, provides an overview of the Foresee Pharmaceuticals, LLC’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of F... -
$6,995 Read More Frontier Pharma: Ovarian Cancer – Identifying and Commercializing First-in-Class Innovation
Ovarian cancer is the sixth most common cancer in females and it also has the highest mortality rate of gynecological cancers. The five-year survival rate is approximately 45%, although the disease is ultimately fatal in the majority of patients due to a high rate of recurrence. Surgery is genera... -
$4,995 Read More Pancreatic Cancer Therapeutics in Major Developed Markets to 2021 – Strong Late Stage Pipeline Holds Promise for Increasingly Div[...]
Pancreatic Cancer (PC) is a disease predominately of the elderly with ~75% of PC cases being diagnosed in patient’s over 75 years old. PC proliferates rapidly, is asymptomatic at its earliest stages and when symptoms do present themselves they are non-specific. There are currently no early detect... -
$4,995 Read More Global Immunology Market to 2022 – Large pipeline and competitive market to drive long-term market growth
Immune-mediated inflammatory diseases are a very common set of chronic disorders that affect 5–7% of western populations. Although they are often disparate in terms of their symptoms and key patient demographics, they are pathophysiologically linked, being characterized by dysregulation of immune... -
$6,995 Read More Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) – Identifying and Commercializing First-in-Class Innovation
Chronic Obstructive Pulmonary Disease (COPD) is a progressive disorder associated with chronic inflammation of the airways and lungs. Persistent breathing difficulties and repeated exacerbations of COPD symptoms make the disease one of the leading causes of morbidity and the fifth-leading cause o...
Sorry, there is no ad related to this category!
-
$4,995 Read More Prostate Cancer Market to 2021 – Increasing Disease Prevalence to be a Key...
Prostate Cancer (PC) is a disease predominately of the elderly with 60% of cases diagnosed […]
-
$2,000 Read More Dilated Cardiomyopathy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Dilated Cardiomyopathy – Pipeline Review, H1 2016’, provides an overview of the […]
-
$2,000 Read More Autism – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Autism – Pipeline Review, H1 2016’, provides an overview of the Autism […]
-
$2,500 Read More Neonatal Respiratory Distress Syndrome Global Clinical Trials Review, H1, 2016
This report provides top line data relating to the clinical trials on Neonatal Respiratory Distress […]
-
$1,500 Read More Oncomatryx Biopharma, S.L. – Product Pipeline Review – 2015
Global Markets Direct’s, ‘Oncomatryx Biopharma, S.L. – Product Pipeline Review – 2015’, provides an overview […]
-
$2,000 Read More Otitis Media – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Otitis Media – Pipeline Review, H1 2016’, provides an overview of the […]
-
$2,000 Read More Duchenne Muscular Dystrophy – Pipeline Review, H1 2016
Global Markets Direct’s, ‘Duchenne Muscular Dystrophy – Pipeline Review, H1 2016’, provides an overview of […]
-
$2,500 Read More Dental Pain Global Clinical Trials Review, H1, 2016
This report provides top line data relating to the clinical trials on Dental Pain. Report […]
-
$4,995 Read More Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 – Growth Driven...
Breast cancer, a malignant neoplasm, is the second-most common cancer and the most common cancer […]
-
$1,500 Read More JCR Pharmaceuticals Co., Ltd. – Product Pipeline Review – 2015
Global Markets Direct’s, ‘JCR Pharmaceuticals Co., Ltd. – Product Pipeline Review – 2015’, provides an […]